Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra M Swain

Showing results (41-50 of 210) with videos related to

Pageof 21
Sort By:
The New England Journal of Medicine|May 14, 2015
Treatment of HER2-positive metastatic breast cancerSandra M Swain, Emma Clark, José Baselga
Nature Reviews. Drug Discovery|November 7, 2022
Targeting HER2-positive breast cancer: advances and future directionsSandra M Swain, Mythili Shastry, Erika Hamilton
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2006
Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancerJanice M Walshe, Neelima Denduluri, Sandra M Swain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Reply to E.J. Moylan et alSandra M Swain, Gong Tang, Charles E Geyer
The New England Journal of Medicine|December 3, 2010
Amenorrhea from breast cancer therapy--not a matter of doseSandra M Swain, Jong-Hyeon Jeong, Norman Wolmark
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Cardiac toxicity in breast cancer survivors: review of potential cardiac problemsBrian R J Healey Bird, Sandra M Swain
JACC. Cardiooncology|March 6, 2023
Potential and Pitfalls of Pharmacovigilance Databases in OncologyIlana Schlam, Michael S Ewer, Sandra M Swain
Cancer|May 27, 2003
Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trialsSandra M Swain, Fredrick S Whaley, Michael S Ewer
Expert Opinion on Investigational Drugs|January 12, 2012
Pazopanib for the treatment of breast cancerLaleh Amiri-Kordestani, Antoinette R Tan, Sandra M Swain
Pharmacology & Therapeutics|June 23, 2018
CDK4/6 inhibitors in breast cancer therapy: Current practice and future opportunitiesFilipa Lynce, Ayesha N Shajahan-Haq, Sandra M Swain
Pageof 21

Showing results (41-50 of 210) with videos related to

Sort By:
Pageof 21
The New England Journal of Medicine|May 14, 2015
Treatment of HER2-positive metastatic breast cancerSandra M Swain, Emma Clark, José Baselga
Nature Reviews. Drug Discovery|November 7, 2022
Targeting HER2-positive breast cancer: advances and future directionsSandra M Swain, Mythili Shastry, Erika Hamilton
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2006
Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancerJanice M Walshe, Neelima Denduluri, Sandra M Swain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Reply to E.J. Moylan et alSandra M Swain, Gong Tang, Charles E Geyer
The New England Journal of Medicine|December 3, 2010
Amenorrhea from breast cancer therapy--not a matter of doseSandra M Swain, Jong-Hyeon Jeong, Norman Wolmark
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Cardiac toxicity in breast cancer survivors: review of potential cardiac problemsBrian R J Healey Bird, Sandra M Swain
JACC. Cardiooncology|March 6, 2023
Potential and Pitfalls of Pharmacovigilance Databases in OncologyIlana Schlam, Michael S Ewer, Sandra M Swain
Cancer|May 27, 2003
Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trialsSandra M Swain, Fredrick S Whaley, Michael S Ewer
Expert Opinion on Investigational Drugs|January 12, 2012
Pazopanib for the treatment of breast cancerLaleh Amiri-Kordestani, Antoinette R Tan, Sandra M Swain
Pharmacology & Therapeutics|June 23, 2018
CDK4/6 inhibitors in breast cancer therapy: Current practice and future opportunitiesFilipa Lynce, Ayesha N Shajahan-Haq, Sandra M Swain
Pageof 21